Header Logo

Connection

Alan Landay to Leukemia, Lymphocytic, Chronic, B-Cell

Back to Details
This is a "connection" page, showing publications Alan Landay has written about Leukemia, Lymphocytic, Chronic, B-Cell.
Alan Landay
Connection Strength
0.363
Leukemia, Lymphocytic, Chronic, B-Cell
  1. Liver X receptor alpha (LXRalpha) as a therapeutic target in chronic lymphocytic leukemia (CLL). J Leukoc Biol. 2009 Nov; 86(5):1019-21.
    View in: PubMed
    Score: 0.363
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.